ZOLMITRIPTAN (zolmitriptan) by Aurobindo Pharma is serotonin 1b receptor agonists [moa]. Approved for serotonin-1b and serotonin-1d receptor agonist [epc]. First approved in 2016.
Drug data last refreshed 18h ago
Serotonin 1b Receptor Agonists
Serotonin-1b and Serotonin-1d Receptor Agonist
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Determine Central 5-HT1B Receptor Occupancy of ZOMIG® Rapimelt (Zolmitriptan) in Healthy Male Volunteers
Efficacy and Tolerability of Zolmitriptan Nasal Spray
Worked on ZOLMITRIPTAN at Aurobindo Pharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.